Next 10 |
home / stock / pacb / pacb articles
U.S. stocks were higher, with the Nasdaq Composite jumping over 50 points on Monday. Shares of Tesla, Inc. (NASDAQ:TSLA) rose sharply during Monday...
U.S. stocks were higher, with the Dow Jones jumping over 150 points on Friday. Shares of Skechers U.S.A., Inc. (NYSE:SKX) rose sharply during Frida...
Over the past twenty days of trading, Pacific Biosciences of California Inc. (NASDAQ: PACB), from March 19, 2024 to April 16, 2024 there is a pote...
U.S. stocks traded mixed toward the end of trading, with the S&P 500 falling around 0.3% on Tuesday. The Dow traded up 0.02% to 37,741.96 while...
Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial res...
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling around 0.2% on Tuesday. The Dow traded up 0.13% to 37,784.21 whi...
U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 100 points on Tuesday. Following the market opening Tuesday, the ...
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, whic...
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, whic...
News, Short Squeeze, Breakout and More Instantly...
Pacific Biosciences of California Inc. Company Name:
PACB Stock Symbol:
NASDAQ Market:
U.S. stocks were higher, with the Nasdaq Composite jumping over 50 points on Monday. Shares of Tesla, Inc. (NASDAQ:TSLA) rose sharply during Monday...
U.S. stocks were higher, with the Dow Jones jumping over 150 points on Friday. Shares of Skechers U.S.A., Inc. (NYSE:SKX) rose sharply during Frida...
2024-04-18 06:00:04 ET Matthew Sykes from Goldman Sachs issued a price target of $2.50 for PACB on 2024-04-18 04:31:00. The adjusted price target was set to $2.50. At the time of the announcement, PACB was trading at $1.4. The overall price target consensus is at $5.50 w...